Ken Fisher's KRYS Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 27,784 shares of Krystal Biotech, Inc. (KRYS) worth $7.18 M, representing 0.00% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Ken Fisher has maintained this position in KRYS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 23,998 shares. Largest reduction occurred in Q2 2023, reducing 29 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Krystal Biotech (KRYS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Krystal Biotech (KRYS) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +23,998 | Add 633.86% | 27,784 | $258.33 |
| Q4 2025 | +3,786 | New Buy | 3,786 | $246.54 |
| Q2 2023 | -29 | Sold Out | 0 | $0.00 |
| Q1 2023 | +29 | New Buy | 29 | $80.03 |
Ken Fisher's Krystal Biotech Investment FAQs
Ken Fisher first purchased Krystal Biotech, Inc. (KRYS) in Q1 2023, acquiring 29 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Krystal Biotech, Inc. (KRYS) for 4 quarters since Q1 2023.
Ken Fisher's largest addition to Krystal Biotech, Inc. (KRYS) was in Q1 2026, adding 27,784 shares worth $7.18 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 27,784 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $7.18 M.
As of the Q1 2026 filing, Krystal Biotech, Inc. (KRYS) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Krystal Biotech, Inc. (KRYS) was 27,784 shares, as reported at the end of Q1 2026.